article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. The Traditional Pharma Model Isn’t Working – It’s Time to Evolve! August 23, 2022. dstansberry@costellocreativegroup.com. The PhRMA Code, The Sunshine Act, & Inflation Reduction. “On

Pharma 52
article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

Prior to joining Novimmune in 2002, she was Head of Immunology and Preclinical Pharmacology at the Serono Pharmaceutical Research Institute, a Senior Scientist and then Head of Immunology at the Glaxo Wellcome Research Institute in Geneva, and a Scientific Member of the Basel Institute for Immunology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Shining a light on Raman for microbiological analysis

European Pharmaceutical Review

7 Raman imaging in pharmaceutical research – an overview The application of Raman spectroscopy in the medical field led to its use in pathogen screening; in turn, this has led to a role in drug development, such as time‑lapse experiments to better understand the bacterial growth‑dependent phenomena and metabolic response to novel antimicrobials.

article thumbnail

PhRMA is going to have to write some big checks

World of DTC Marketing

percent of total health-care spending—in 2016, the last year for which there are definitive data. The Pharmaceutical Research and Manufacturers of America raised nearly $527 million last year and spent roughly $506 million, new tax returns obtained by OpenSecrets reveal. Leading lobbying industries in the U.S.

article thumbnail

Trump’s lie on drug prices

World of DTC Marketing

On January 4, 2021, two days before the insurrection and 16 days before Trump’s term ended, his administration proposed a new rule on drug prices, a major issue in both the 2016 and 2020 campaigns. Novo Nordisk, for example, raised the price of its widely used Novolog insulin 353 percent from its introduction in 2001 to 2016.